Catalio Capital Management, LP β Full Portfolio
106 tracked investments Β· listed companies and verified rows first
AtaiBeckley develops rapid-acting mental health treatments and therapies for patients with difficult-to-treat mental health conditions.
BiotechDeep TechDigital HealthMedical DevicesMental Health
Srinivas Rao(Co-Founder and Chief Executive Officer)Christian Angermayer(Founder and Chairman of the Board)
Co-investorsAble PartnersAlpha Wave GlobalFJ LabsFuture VenturesLeafy TunnelNucleus Adventure Capital+3 more
Avalyn Pharma develops inhaled therapies for pulmonary fibrosis, using a nebulization approach that delivers treatment directly to the lungs to reduce the tolerability problems of existing oral therapies.
BiotechHealthtech
Lyn Baranowski(CEO)in
Co-investorsAndera PartnersF-Prime CapitalInVivium CapitalNorwest Venture PartnersRiverVest Venture PartnersSR One Capital Management+7 more
Compass Pathways develops psychedelic-based treatments for mental health conditions, aiming to create a new clinical standard for patients underserved by current care.
BiotechDigital HealthMental Health
Co-investorsAble PartnersAisling CapitalNoeticOMX VenturesVivo CapitalJam Fund
Fractyl develops therapies for obesity and type 2 diabetes, focusing on non-drug-based approaches rooted in understanding metabolic disease mechanisms.
BiotechHealthtechMedical DevicesLexington, US
HARITH RAJAGOPALAN(Executive Officer, Director)inJAY CAPLAN(Executive Officer, Director)inJay Caplan(Executive Officer, Director)inHarith Rajagopalan(Executive Officer, Director)inLISA DAVIDSON(Executive Officer)inDiane Marcou(Executive Officer)in
Co-investorsBessemer Venture PartnersEmergent Medical Partners, LLPMithril Capital ManagementPolaris PartnersVeltro Argento
Freenome develops early-stage cancer detection technology using blood tests to identify cancer in its earliest, most treatable phases.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesLondon
Riley Ennis(Co-Founder and Chief Product Officer)inCharles Roberts(Director)inGabriel Otte(Director)in
BoardStuart Lawson(Director)
Co-investorsRA CapitalAME Cloud VenturesAndreessen HorowitzArtis VenturesAsset Management CompanyAverin Capital+8 more
Kardigan develops targeted cardiovascular treatments through a discovery and translational research platform, with a pipeline of late-stage drug candidates aimed at functional cures for cardiovascular disease.
AI & Machine LearningBiotechHealthtechMedical Devices
Co-investorsARCH Venture PartnersT. Rowe Price
Neumora is a clinical research company developing investigational medications, with a focus on conducting clinical trials to obtain regulatory approval and make treatments available to patients.
BiotechDeep TechDigital HealthMedical DevicesWatertown, US
Joshua Pinto(Executive Officer)Tamara Tompkins(Executive Officer)inKari Stefansson(Director)Maykin Ho(Director)Alaa Halawa(Director)
BoardKristina Burow(Director)in
Co-investorsARCH Venture PartnersF-Prime CapitalK2 HealthVenturesMercury FundPremier PartnersSoftBank Vision Fund+2 more
Helicons develops a peptide-based therapeutic platform designed to target intracellular proteins previously considered undruggable by combining the specificity of antibodies with the cell-penetrating properties of small molecules.
AI & Machine LearningBiotechDeep TechMedical Devices
Mathai Mammen(CEO, President and Chairman)in
Co-investorsARCH Venture PartnersForesite CapitalFrazier Life SciencesGeneral CatalystNextech InvestRA Capital+5 more
Protara develops transformative therapies for patients with cancer and rare diseases, applying modern scientific and manufacturing advancements to accelerate drug development.
BiotechHealthtechMedical Devices
9amHealth provides virtual care for cardiometabolic conditions, offering weight management, diabetes care, and heart health treatment that combines prescription medication (including GLP-1s), lifestyle coaching, and lab testing.
Digital HealthHealthtechWellness & FitnessEncinitas, US
Frank Westermann(Executive Officer, Director)inAnton Kittelberger(Founder)inMichael Hofner(Executive Officer)inAvantika Waring(Executive Officer)Paul Geevarghese(Executive Officer)inBernhard Schandl(Executive Officer)in
Co-investors7wire VenturesCalm/Storm VCHabitat PartnersHansmann Family OfficePUSH VenturesSemperVirens Venture Capital+1 more
Abridge builds AI software that converts clinical conversations into structured insights for healthcare providers.
AI & Machine LearningDigital HealthHealthtechPhiladelphia, US
Shiv Rao(Founder & CEO)inShiv (Shivdev) Rao(Founder)inJulia Chapin(Executive Officer)Sagar Sanghvi(Executive Officer)in
BoardAndy Weissman(Director)inSebastian Duesterhoeft(Director)in
Co-investorsAlpha Square Groupalphabet angelsAndreessen HorowitzBessemer Venture PartnersCapitalGCollective Liquidity+20 more
AdvanCell is a clinical-stage radiopharmaceutical company developing a pipeline of targeted alpha therapies for the treatment of cancers including prostate, melanoma, ovarian, breast, and lung.
BiotechHealthtechMedical DevicesCambridge, US
Andrew Adamovich(Director)inPhilina Lee(Executive Officer, Director)inAaron Pickett(Executive Officer)in
BoardWing Cheong Lam(Director)Nik Economopoulos(Director)Anthony Aiudi(Director)
Co-investorsBain Capital Life SciencesProto AxiomSV Health InvestorsTenmileAbingworthAlly Bridge Group+2 more
Alentis is a biotech company developing therapies for chronic liver disease, fibrosis, and cancer based on the molecular biology of liver disease.
AI & Machine LearningBiotechHealthtechMedical DevicesBasel, CH
Thomas Baumert(Founder)inMark Pruzanski(Chief Executive Officer)inLuigi Manenti(Chief Medical Officer)Jon Freve(Chief Financial Officer)Bryan Yoon(General Counsel and Chief Administrative Officer)inAditya Venugopal(Chief Business Officer)in
Co-investorsAvego BioScience CapitalBioMedPartnersFrazier Life SciencesJeito CapitalLongitude CapitalNovo Holdings+5 more
Amalgam builds a modular, AI-powered Software as a Medical Device (SaMD) platform and EHR-integrated solutions for life sciences companies, health plans, and providers to support clinical decisions, patient engagement, and digital therapeutics.
AI & Machine LearningDigital HealthHealthtechWilmington, US
Ryan Sysko(Founder)in
BoardSONNY VU(Director)JEFFREY P. COURTNEY(Director)
Co-investorsCVS Health VenturesSupermorpheus
ArriVent BioPharma is a clinical-stage biopharmaceutical company focused on identifying, developing, and commercializing medicines for difficult-to-treat diseases, starting with cancers.
BiotechHealthtechMedical DevicesNewtown Square, US
Zhengbin (Bing) Yao(Executive Officer, Director)inBrent Rice(Chief Commercial Officer)in
BoardJason Zhang(Director)Cong Xu(Director)Stuart Lutzker(Director)
Co-investorsForesite CapitalGeneral CatalystHongShan Capital GroupLAVLilly Asia VenturesOrbiMed+2 more
BiotechRedwood City, US
Jeffrey Cleland(Manager of Company)Kannan Rangaramanujam(Manager of Company)Sujatha Kannan(Manager of Company)
BoardJustin Hanes(Manager of Company)in
AtaiBeckley develops rapid-acting mental health treatments for patients with difficult-to-treat conditions through rigorous scientific research and clinical applications.
BiotechDigital HealthHealthtechMental Health
Srinivas Rao(Co-Founder and Chief Executive Officer)Christian Angermayer(Founder and Chairman of the Board)
Co-investorsatai Life SciencesAtaiBeckley
New York-based D2C provider of high-quality hearing aids in the US.
HealthtechNew York, US
Patrick Freuler(Executive Officer, Director)Andre Sequin(Executive Officer)
Co-investorsECONA AGTIA VenturesHOWZAT Partners
BiotechCambridge, US
Mohamed Genead(Executive Officer, Director)inMichael Tolentino(Executive Officer, Director)inDavid Callanan(Executive Officer)inTarek Hassan(Executive Officer)inDerek Kunimoto(Executive Officer)in
BoardDavid Guyer(Director)
Co-investorsJeito CapitalLongitude Capital
Axena Health develops digital therapeutic devices for women's pelvic health, specifically treating urinary and fecal incontinence through at-home pelvic floor muscle training.
Digital HealthFemTechHealthtechMedical DevicesAuburndale, US
Samantha Pulliam(CEO and Chief Medical Officer)inVincent Ricci(Executive Officer)Jim O'Connor(Executive Officer)inShacey Petrovic(Executive Officer, Director)inEileen Maus(Executive Officer, Director)in
BoardJonathan Dean(Director)
Co-investorsCross-Border Impact VenturesAvestria Ventures
Bayesian Health develops clinical artificial intelligence for real-time patient monitoring and clinical decision support.
AI & Machine LearningDigital HealthHealthtechMedical Devices
Suchi Saria(Founder and CEO)in
Co-investorsAndreessen HorowitzEpsilon Health InvestorsHealth2047 Capital Partners LLCLifeforce CapitalMemorialCare Innovation Fund
Boston, US
Jacob A. Donoghue, M.D., Ph.D.(Executive Officer, Director)Jarrett Revels(Executive Officer)Jacob A. Donoghue(Executive Officer, Director, Promoter)
BoardCaitlin Donovan(Director)Pavel Raifeld(Director)Naveen Rao(Director)
Co-investorsGeneral CatalystGV (Google Ventures)Iaso VenturesKicker VenturesCasdin CapitalIndicator Ventures+1 more
Blackrock Neurotech develops a neurotechnology platform, including brain-computer interface systems, aimed at improving patient lives and treating neurological conditions.
BiotechDeep TechMedical Devices
Florian Solzbacher(Co-Founder & CSO)Marcus Gerhardt(Co-Founder & CEO)inThomas Thiele(CFO)
BoardChristian Angermayer(Co-Chairman)Tim Sievers(Co-Chairman)
Co-investors2050 CapitalForepont Capital Partners
Cambrian Bio is a clinical-stage drug development company creating precision therapeutics that target metabolic pathways which decline with age, such as AMPK and mTOR.
BiotechHealthtechLongevityNew York, US
James G. Peyer(Executive Officer, Director)inJames Peyer(CEO, Founder, Board Director)inJames Peyer, PhD(Founder)inMark Nuttall(Chief Business Officer)inRuth Thieroff-Ekerdt(Chief Medical Officer)inWilliam DeVaul(Executive Officer)in
Co-investorsFuture VenturesKhosla VenturesKorify CapitalSprint VcStrawberry Creek Venturesatai Life Sciences
Combines single-cell RNA analysis technology from the Broad Institute with AI/ML models and large-scale clinical sample collection for novel drug discovery and precision medicine.
HealthtechCambridge, US
Tariq Kassum(Executive Officer, Director)Michael Boretti(Executive Officer)Christoph Lengauer(Executive Officer, Director)
Co-investorsFast Track InitiativeAlexandriaCasdin CapitalGV (Google Ventures)Third Rock Ventures
Centenara Labs is a longevity-focused drug discovery company that translates research on the biology of aging into therapies intended to improve healthy aging and extend lifespan.
BiotechHealthtechLongevity
Christian Angermayer(Founder)in
Co-investorsKorify CapitalP53 Invest
Centrexion develops therapies for the treatment of pain, focusing on the design and execution of clinical trials for pain drug development.
BiotechHealthtechBaltimore, US
James N. Campbell(President, Chief Scientific Officer)Kerrie L. Brady(Executive Officer)inGregg Beloff(Executive Officer)Jeffrey B. Kindler(Chief Executive Officer)inCharles Oh(Chief Medical Officer)inSmital Shah(Acting CBO)in
Co-investorsEFung CapitalNew Enterprise Associates (NEA)Quan Capital
Character Bio is a precision medicine company that integrates genomics, longitudinal clinical data, imaging, and AI-based biomarker analysis to identify genetic drivers of progressive polygenic eye diseases such as age-related macular degeneration and glaucoma.
AI & Machine LearningBiotechDigital HealthJersey City, US
Cheng Zhang(Executive Officer, Director)in
BoardVivek Garipalli(Director)Nick Olsen(Director)Peter DiLaura(Director)
Co-investorsaMoonCantos VenturesDuke Capital PartnersLifeforce CapitalSanofi VenturesCatalio Capital Management+3 more
Clasp Therapeutics develops off-the-shelf precision T cell engagers (its proprietary pHLΠre molecules) that target mutant peptide-HLA complexes displayed on cancer cells, directing T cells to destroy tumors carrying common driver mutations such as KRas.
BiotechHealthtechCambridge, US
Co-investorsCure VenturesVivo CapitalCatalio Capital ManagementNovo HoldingsThird Rock Ventures
Cresilon develops plant-based flowable hemostatic gel technology that controls bleeding within seconds without manual pressure, with products for veterinary care (VETIGEL) and human trauma (TRAUMAGEL).
BiotechHealthtechMedical DevicesNew MaterialsBrooklyn, US
Isaac Miller(Co-founder)inJoe Landolina(Co-founder & CEO)inScott Levine(Executive Officer)in
Co-investorsDorm RoomInnovating Capital
Biotechnology company using multiplex gene editing to develop genetically engineered porcine organs for human transplantation.
BiotechBrookline, US
Luhan Yang(President, Secretary and Treasurer)Geoff MacKay(Chief Executive Officer)
BoardGeorge M. Church(Director)
Co-investorsAlta PartnersARCH Venture PartnersKhosla VenturesOUP (Osage University Partners)b2ventureKendall Capital Partners
Co-investorsGeneral CatalystRA Capital
Ensoma is a genomic medicine company developing a platform for in vivo engineering of hematopoietic stem cells (HSCs), combining an off-the-shelf delivery system with a gene engineering toolkit intended to treat diseases with a one-time treatment.
BiotechHealthtechMedical DevicesBoston, US
Co-investors5AM VenturesAju IB Invesment CorporationDelos CapitalF-Prime CapitalSolasta VenturesAlexandria+7 more
Clinical-stage biotech using AI and metabolomics to decode natural chemistry and discover small-molecule medicines.
Viswa Colluru, PhD(Founder)in
Co-investorsAir Street CapitalFPVHummingbird VenturesJAZZ Venture PartnersKinnevikLevel Ventures+6 more
Erisyon is a biotechnology company that develops technology to advance scientific and health discoveries, building on research from the University of Texas at Austin's Center for Systems and Synthetic Biology.
BiotechDeep TechHealthtech
Co-investorsFoothill Ventures
FogPharma develops ultra-tunable Helicon peptide therapeutics designed to reach historically undruggable targets, aiming to treat cancer and other serious diseases.
BiotechBoston, US
Gregory L Verdine(Executive Officer, Director)Mathai Mammen(CEO, President and Chairman)in
Co-investorsHorizons VenturesGV (Google Ventures)venBio Global Strategic
Georgiamune is a biopharmaceutical company developing targeted immunomodulator drugs that activate or down-modulate immune signaling pathways to treat cancer and autoimmune diseases.
BiotechDeep TechHealthtechGaithersburg, US
Samir N. Khleif(Founder & CEO)inRamy Ibrahim(Chief Medical and Strategy Officer)inMikayel Mkrichyan(Senior Vice President of Science and Discovery)Sarah Sharman(Vice President of IP Legal Affairs)
BoardSean Parker(Director)Elena Viboch(Director)
Co-investorsHAWKTAILLauder PartnersPrevail Venture CapitalGeneral CatalystJohnson & Johnson Innovation β JJDC
GlycoEra develops glycan-based therapeutics, applying glycoengineering technology to create biologic drugs.
BiotechHealthtechNewton, US
Ganesh V. Kaundinya(President & CEO)in
Co-investors5AM VenturesLifeArc VenturesRoche Venture FundSixty Degree CapitalSofinnova PartnersAgent Capital+1 more
Hippocratic AI develops generative AI agents designed for healthcare delivery, working with hospital systems, health plans, and life sciences companies to support clinical decision-making and patient care.
AI & Machine LearningDigital HealthHealthtech
Munjal Shah(Chief Executive Officer, Co-founder)inDr. Meenesh Bhimani(Chief Medical Officer, co-founder)inVishal Parikh(Chief Product Officer, Co-founder)inSubho Mukherjee(Chief Science Officer, Co-founder)inSaad Godil(Founder)inSubhabrata (Subho) Mukherjee(Founder)in
Co-investorsAndreessen HorowitzGeneral CatalystAvenir Growth CapitalFounders Circle CapitalGreycroftHakluyt Capital+4 more
Iambic develops AI technologies for drug discovery, using a high-throughput experimental platform to design small-molecule medicines and advance a pipeline of clinical candidates for cancers such as HER2-driven, breast, and ovarian tumors.
AI & Machine LearningBiotechDeep TechSan Diego, US
Tom Miller(Co-Founder & CEO)inFred Manby(Co-Founder & CTO)inThomas Miller(Founder)inNeil Josephson(Chief Medical Officer)inPete Olson(Chief Scientific Officer)inMichael Secora(Chief Financial Officer and Chief Corporate Development Officer)in
Co-investorsAbingworthAscenta CapitalCatalio Capital ManagementAlumni VenturesCoatue ManagementEisai Innovation, Inc.+4 more
Immunai develops AMICA, a data platform for decoding the immune system to accelerate drug discovery and development.
AI & Machine LearningBiotechData & InfrastructureNew York City, US
Co-investorsGefen CapitalKoch Disruptive TechnologiesMeron CapitalPerot JainTLV PartnersViola Ventures
Co-investorsBain Capital Life Sciences
Insightec develops Exablate Neuro, an MRI-guided focused ultrasound platform that treats Essential Tremor and tremor-dominant Parkinson's Disease through an incision-free outpatient procedure.
HealthtechMedical DevicesTirat Carmel
Roni Karie(Vice President - Finance)Shirel Aroshase(Vice President - Human Resources)inEyal Zadicario(General Manager)inMenashe Frank(Vice President - Legal)inJun (Jim) Tao(Chief Operating Officer)inMaurice R. Ferre(Chairman and Chief Executive Officer)in
Co-investorsExigent CapitalGEOCJazzya InvestmentsKoch Disruptive TechnologiesKrillion VenturesPeregrine Ventures+7 more
Kailera Therapeutics is a clinical-stage biopharmaceutical company developing a pipeline of product candidates for people living with obesity.
BiotechHealthtech
Co-investorsAtlas VentureBain Capital Life Sciences
Lassen Therapeutics is a biotechnology company developing therapeutics targeting IL-11, with a pipeline focused on immune and fibrotic diseases.
Biotech
David King(Co-Founder & CSO)inMaria Fardis(CEO)inCadmus C. Rich(Chief Medical Officer)inElaine Stracker(General Counsel)in
Co-investorsAlta PartnersDC Investment PartnersLongitude CapitalLongwood FundBiotechnology Value FundCatalio Capital Management+2 more
Leo Cancer Care develops upright radiotherapy and particle therapy solutions that integrate CT imaging with patient positioning systems.
Deep TechHardwareHealthtechMedical Devices
Co-investorsYu GalaxyMana VenturesSerra Ventures
LifeSprout develops synthetic materials that mimic the body's own tissues for aesthetic and regenerative medicine, creating products to treat patients with soft tissue loss from aging, cancer, and metabolic disease.
BiotechMedical DevicesNew MaterialsBaltimore, US
Hai-Quan Mao(Co-founder, PhD)Sashank Reddy(Co-founder, MD, PhD)Kevin Colbert(Co-founder, Business Development)inRuss Martin(Co-founder, Head of R&D, PhD)inAdam Gridley(Executive Chairman, MBA)
Co-investorsEmerald Development ManagersMaryland TEDCOTEDCO
LILA Sciences builds AI systems for autonomous scientific research and discovery across medicine, materials, energy, and defense sectors.
AI & Machine LearningBiotechDeep TechSaaS
Co-investorsDauntless VenturesFlagship PioneeringMarch Capital PartnersModi VenturesCollective GlobalIn-Q-Tel+1 more
Metagenomi Therapeutics is an in vivo genome editing company that uses genetic material sourced from natural environments (metagenomics) to develop a toolbox of editing tools for deletion, integration, and correction of genetic mutations.
BiotechDeep TechMedical DevicesBerkeley, US
Brian Thomas(Executive Officer, Director, Promoter)in
BoardAndrew Farquharson(Director)Jak Knowles(Director)
Co-investorsRA CapitalSozo VenturesAgent CapitalHumboldtInCube VenturesLeaps by Bayer+1 more
NextPoint is a precision therapeutics company developing cancer treatments targeting the B7-H7/HHLA2 axis, including a T-cell engager, an antibody-drug conjugate with proprietary linker technology, and a multi-functional checkpoint inhibitor.
BiotechHealthtechAustin, US
Gordon Freeman(Scientific Founder)XingXing Zang(Scientific Founder)inIvan Cheung(Chief Executive Officer)inLeena Gandhi(Chief Medical Officer)inTatiana Novobrantseva(Chief Scientific Officer)inAxel Hoos(Director)
Co-investorsMPM BioImpactSanofi VenturesCatalio Capital ManagementInvusLeaps by BayerSixty Degree Capital
Octant is a therapeutics company that develops small molecule drugs to treat protein misfolding diseases.
AI & Machine LearningBiotechDeep TechMedical DevicesEmeryville, US
Sri Kosuri(Co-founder)inRamsey Homsany(Founder)in
Co-investorsAndreessen Horowitz+ND Capital8VCCarbon SiliconFifty YearsFlucas Ventures+5 more
Odyssey Therapeutics develops small molecule and protein therapeutics targeting upstream signaling nodes and innate immune system mechanisms to prevent pathological inflammation.
BiotechMedical DevicesCambridge, US
Gary D Glick(Executive Officer, Director)in
BoardJill Carroll(Director)inCarl Gordon(Director)inValerie Odegard(Director)Jeffrey Leiden(Director)Charles Baum(Director)
Co-investorsActivant CapitalBalderton CapitalForesite CapitalGlobal BioAccess FundGreatPoint VenturesJeito Capital+6 more
OnCusp Therapeutics develops oncology therapeutics for cancer treatment, including antibody-drug conjugates and small molecule compounds in clinical and preclinical stages.
BiotechMedical DevicesNew York, US
Dr. Bing Yuan(Co-Founder, Chief Executive Officer)Dr. Eric Slosberg(Co-Founder, Chief Development Officer)Dr. Andy Fu(Co-Founder, Chief Business Officer)
Co-investorsOrbiMedF-Prime CapitalSofinnova VenturesInsight PartnersNVIDIA
AI company developing a medical search engine used by physicians for clinical decision support.
Daniel Nadler(Founder & CEO)inZachary Ziegler(Founder)
Co-investorsAlkeon InnovationAmity VenturesAndreessen HorowitzBreyer CapitalCoatue ManagementCold Start Ventures+15 more
Orasis is a pharmaceutical company developing drugs for the eye, operating in the ophthalmology and eyecare space.
BiotechHealthtechMedical Devices
Co-investorsArboretum VenturesMaverick Ventures IsraelVisionary VenturesCatalio Capital ManagementJohnson & Johnson Innovation β JJDCLifeSci Venture Partners+1 more
HealthtechNew York, US
David Klimstra(Executive Officer)Thomas Fuchs(Director)William Andrew Moye(Executive Officer, Director)Peter Hamilton(Executive Officer)Antoine Munfa(Director)Jim Beyer(Director)
Co-investorsCasdin Capital
BiotechSouth San Francisco, US
Watson Debi(Director)Anne Rubin(Executive Officer, Director)Kirsten Angela Macfarlane(Executive Officer, Director, Promoter)Cameron Wheeler(Director)Randall Olson(Director)Robert Jackson(Director)
Perfuse Therapeutics develops novel ocular therapies for retinal and glaucoma diseases through drug delivery and formulation platforms.
BiotechHealthtechMedical DevicesSan Francisco, US
Sevgi Gurkan, MD(Founder, Chief Executive Officer, and Member of the Board of Directors)
BoardChristy Shaffer(Director)Chau Khuong(Director)inSevgi Gurkan(Executive Officer, Director, Promoter)in
Co-investorsOrbiMedAccess BiotechnologyHatteras Venture PartnersLAVLilly Asia VenturesHatteras
A precision oncology company providing genomic testing and resources to support cancer care decisions, operating under Labcorp Oncology.
BiotechDigital HealthHealthtechMedical DevicesBaltimore, US
Victor Velculescu(Executive Officer, Director, Promoter)inLuis A. Diaz, Jr.(Executive Officer, Director, Promoter)Sam Angiuoli(Executive Officer)inSian Jones(Executive Officer)inLisa Kann(Executive Officer)inAnthony Newton(Executive Officer)
Co-investors3B Future Health FundCo-Win VenturesNew Enterprise Associates (NEA)Windham Capital PartnersVensana Capital
Pheast Therapeutics develops immunotherapies targeting cancer, building on foundational research from Stanford's stem cell research institute.
BiotechHealthtechMedical DevicesRedwood City, US
Irv Weissman(Cofounder, Scientific Advisor, Board Director)Ravi Majeti(Cofounder, Scientific Advisor, Board Observer)Amira Barkal(Principal Founder, Scientific Advisor, Board Director)inRoy Maute(Cofounder & Chief Executive Officer)in
BoardJacob Vogelstein(Director)Steven Gillis(Director)in
Co-investorsARCH Venture Partners
Pillar Biosciences develops kitted next-generation sequencing (NGS) panels and its SLIMamp single-tube library preparation technology for clinical and research laboratories, focused on cancer diagnostics.
BiotechDigital HealthHealthtechMedical DevicesNatick, US
Shawn Liu(Director)Hui Yang(Director)Gang Song(Executive Officer, Director)Zhaohui Wang(Director)Robert Forrester(Director)Hong Fang Song(Director)
Co-investorsHB Ventures
Port Therapeutics is a company focused on cancer immunotherapy development.
BiotechHealthtech
Lena Gamboa(Head of Cancer Immunotherapy)inSteve Altschuler(Executive Chair)in
ProSomnus offers oral appliance devices for treating obstructive sleep apnea and snoring, positioned as an alternative to CPAP machines.
Digital HealthHealthtechMedical DevicesWellness & FitnessPleasanton, US
Leonard Liptak(Executive Officer, Director)Sung Kim(Executive Officer)Jason Orchard(Director)Steven Pacelli(Director)Heather Rider(Director)Laing Rikkers(Executive Officer, Director)
Recognify is a biotech company developing therapeutic and diagnostic products for CNS disease, oncology, and infectious disease.
BiotechDigital HealthMental Health
Gary Walker(Founder, VP Clinical Development)Thomas C. SΓΌdhof(Founder, Chairman of SAB)Angela Macfarlane(Founder, Board Member, Business Advisor)Matt Pando(Founder, CEO/President)
Recursion applies artificial intelligence and large-scale data analysis to accelerate drug discovery and development.
AI & Machine LearningBiotechDeep TechMedical DevicesSalt Lake City, US
Chris Gibson(Co-founder, Chairman of the Board)
Co-investorsDCVC (Data Collective)Lux CapitalBaillie GiffordAir Street CapitalAmplify PartnersCentral Texas Angel Network+8 more
RefleXion Medical develops SCINTIX autonomous radiotherapy, an external beam theranostic oncology platform that uses biological signals from radiopharmaceutical-labeled cancer cells to deliver real-time, motion-managed radiation to lung and bone tumors from primary or metastatic disease.
BiotechHealthtechMedical DevicesHayward, US
Samuel Mazin(Executive Officer, Director)inAkshay Nanduri(Executive Officer, Director)in
BoardJay Watkins(Director)
Co-investorsAscension VenturesPfizer Venture InvestmentsSofinnova PartnersSonder CapitalVenrockSonder Futures
Centenara Labs develops and invests in therapeutics targeting geriatric and age-related diseases, aiming to extend healthspan and lifespan.
BiotechHealthtechLongevity
Co-investorsQCΒ·VENTURES
Resilience is a contract development and manufacturing organization (CDMO) that manufactures complex pharmaceutical products and active pharmaceutical ingredients to broaden access to medicines and protect biopharmaceutical supply chains against disruption.
Advanced ManufacturingBiotechEnterprise SoftwareBlue Ash, US
William S. Marth(Chief Executive Officer)
BoardRobert Nelsen
Co-investors8VCARCH Venture PartnersGV (Google Ventures)Koch Disruptive TechnologiesLux CapitalMagnetic Ventures+4 more
Rhapsogen is developing a precision biologic therapy aimed at treating autoimmune diseases, focused on efficacy, safety, and durability.
BiotechHealthtech
Sherman Oaks, US
Brian Neman(Executive Officer, Director)Randy Socol(Executive Officer)
BoardTim Triche(Director)Rudiger Hausherr(Director)
Septerna is a biotechnology company that uses its proprietary Native Complex Platform to discover and develop oral small molecule therapies targeting GPCRs for endocrinology, immunology and inflammation, and metabolic diseases.
AI & Machine LearningBiotechDeep TechSouth San Francisco, US
Robert Lefkowitz(Founder)Arthur Christopoulos(Founder)Patrick Sexton(Founder)Ran Xiao(Executive Officer)Elizabeth Bhatt(Executive Officer)Samira Shaikhly(Executive Officer)
Co-investorsRA CapitalSamsara BioCapitalVertex Ventures HCThird Rock Ventures
SetPoint Medical develops an FDA-approved implantable neurostimulation device that stimulates the vagus nerve to reduce inflammation, offering a device-based treatment for adults with moderate-to-severe rheumatoid arthritis who have not responded to biologic or targeted synthetic drugs.
BiotechHealthtechMedical DevicesValencia, US
Murthy Simhambhatla(CEO)inDavid Chernoff(Chief Medical Officer (MD))Yaakov Levine(PhD)inRohan Seth(Executive Officer)in
BoardBlake Wu(Director)Juan-Pablo Mas(Director)
Co-investorsAlly Bridge GroupNew Enterprise Associates (NEA)Norwest Venture PartnersTopspin PartnersCitta CapitalLightstone Ventures+4 more
HealthtechCambridge, US
Rahul Dhanda(Executive Officer, Director)James Collins(Director)David Walt(Director)in
BoardIssi Rozen(Director)in
Co-investorsIllumina VenturesGV (Google Ventures)
Singular Genomics develops spatial pathology technology to map molecules and cells directly in tissue for disease characterization.
BiotechDeep TechMedical Devices
John Stark(CEO)Aaron Berlin(CTO)
Co-investorsARCH Venture PartnersCoatue ManagementF-Prime Capital
HealthtechBaltimore, US
Carolyn Reed Yarina(Executive Officer, Director)Katherine Kirsch(Executive Officer, Director)Gillian Henker(Executive Officer, Director)
Co-investorsBelle Impact FundGolden Seeds
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.